24 HR gepirone 18.2 MG Extended Release Oral Tablet [Exxua]
- RxCUI
- 2672379
- RxNorm name
- 24 HR gepirone 18.2 MG Extended Release Oral Tablet [Exxua]
- Display name
- 24 HR gepirone 18.2 MG Extended Release Oral Tablet [Exxua]
- Full name
- 24 HR gepirone 18.2 MG Extended Release Oral Tablet [Exxua]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EXXUA | GEPIRONE | Aytu Therapeutics, LLC | 0c78edd8-6acb-433c-9d34-2527da8d64e1 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | 2672379 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0c78edd8-6acb-433c-9d34-2527da8d64e1 | EXXUA 18.2 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR gepirone 18.2 MG Extended Release Oral Tablet [Exxua] [SBD] · 24 HR Exxua 18.2 MG Extended Release Oral Tablet [SY] · Exxua 18.2 MG (equivalent to 20 MG gepirone hydrochloride) 24 HR Extended Release Oral Tablet [SY] | 4 | 2 | These highlights do not include all the information needed to use EXXUA ™ safely and effectively. See full prescribing information for EXXUA . EXXUA ( gepirone ) extended-release tablets for oral use Initial U.S. Approval: 2023 | 20251016 |